✦ LIBER ✦

The cost-effectiveness of bevacizumab in the first-line treatment of metastatic colorectal cancer in England and Wales

✍ Scribed by P. Tappenden; R. Jones; S. Paisley; C. Carroll

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab in the first-line treatment

✍ David Cameron 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Bevacizumab in the treatment of metastat

✍ Caprioni, Francesco; Fornarini, Giuseppe 📂 Article 📅 2007 🏛 Future Medicine 🌐 English ⚖ 405 KB

Clinical and Cost Effectiveness of Bevac

✍ Eui-Kyung Lee; Cedric Revil; Charles A. Ngoh; Johanna Lister; Jeong-Mi Kwon; Mee 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 460 KB

Bevacizumab in First-Line Treatment of M

✍ David Miles 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 46 KB

Bevacizumab in First-Line Treatment of M

✍ Xavier Pivot 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 45 KB

PCN11 Bevacizumab in Combination with Ch

✍ Ubago, R.; Castillo, M.A.; Flores, S.; Beltrán, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB